These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 24687338

  • 21. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I, Rigal-Huguet F, Vekhoff A, Desablens B, Bordessoule D, Mounier C, Ferrant A, Sanz M, Fey M, Chomienne C, Chevret S, Degos L, Fenaux P, European APL group experience.
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [Abstract] [Full Text] [Related]

  • 22. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study.
    Imaizumi M, Tawa A, Hanada R, Tsuchida M, Tabuchi K, Kigasawa H, Kobayashi R, Morimoto A, Nakayama H, Hamamoto K, Kudo K, Yabe H, Horibe K, Tsuchiya S, Tsukimoto I.
    Br J Haematol; 2011 Jan; 152(1):89-98. PubMed ID: 20735397
    [Abstract] [Full Text] [Related]

  • 23. [Acute promyelocytic leukemia (APL) resulting in broad cerebral infarction during all-trans retinoic acid (ATRA) treatment].
    Ikeda Y, Yoshinaga K, Iki S, Ohbayashi Y, Urabe A.
    Rinsho Ketsueki; 1994 Feb; 35(2):183-7. PubMed ID: 8139118
    [Abstract] [Full Text] [Related]

  • 24. Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
    Finsinger P, Breccia M, Minotti C, Carmosino I, Girmenia C, Chisini M, Volpicelli P, Vozella F, Romano A, Montagna C, Colafigli G, Cimino G, Avvisati G, Petti MC, Lo-Coco F, Foà R, Latagliata R.
    Ann Hematol; 2015 Feb; 94(2):195-200. PubMed ID: 25186786
    [Abstract] [Full Text] [Related]

  • 25. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S.
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [Abstract] [Full Text] [Related]

  • 26. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR.
    Clin Lab Sci; 2000 Nov; 13(2):106-16. PubMed ID: 11066449
    [Abstract] [Full Text] [Related]

  • 27. [Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia].
    Savchenko VG, Parovichnikova EN, Isaev VG, Shuravina EN, Demidova IA, Ol'shanskaia IuV.
    Ter Arkh; 2002 Nov; 74(7):11-8. PubMed ID: 12181827
    [Abstract] [Full Text] [Related]

  • 28. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
    Bassan R, Battista R, Viero P, d'Emilio A, Buelli M, Montaldi A, Rambaldi A, Tremul L, Dini E, Barbui T.
    Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
    [Abstract] [Full Text] [Related]

  • 29. Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
    Fenaux P.
    Leukemia; 1994 Feb; 8 Suppl 3():S70-2. PubMed ID: 7808029
    [Abstract] [Full Text] [Related]

  • 30. All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.
    Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F.
    Blood; 1992 Nov 01; 80(9):2176-81. PubMed ID: 1421389
    [Abstract] [Full Text] [Related]

  • 31. [Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children].
    Chen J, Gu LJ, Tang JY, Xue HL, Pan C, Ye QD, Jiang H, Dong L, Zhou M, Wang YP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun 01; 10(3):329-32. PubMed ID: 18554461
    [Abstract] [Full Text] [Related]

  • 32. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
    Ortega JJ, Madero L, Martín G, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA, PETHEMA Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7632-40. PubMed ID: 16234524
    [Abstract] [Full Text] [Related]

  • 33. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM, Kantarjian HM, Estey EH.
    Leuk Lymphoma; 1996 Feb 20; 20(5-6):435-9. PubMed ID: 8833399
    [Abstract] [Full Text] [Related]

  • 34. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH.
    N Engl J Med; 1997 Oct 09; 337(15):1021-8. PubMed ID: 9321529
    [Abstract] [Full Text] [Related]

  • 35. Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review.
    Wang L, Yan X, He J.
    Medicine (Baltimore); 2020 Oct 23; 99(43):e22923. PubMed ID: 33120845
    [Abstract] [Full Text] [Related]

  • 36. The role of standard-dose cytarabine in children with acute promyelocytic leukemia: a single-center experience.
    Zhang L, Zhu X, Chen X, Chen Y, Zou Y.
    J Pediatr Hematol Oncol; 2011 Mar 23; 33(2):e46-50. PubMed ID: 21127433
    [Abstract] [Full Text] [Related]

  • 37. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G.
    Haematologica; 1999 Nov 23; 84(11):963-8. PubMed ID: 10553155
    [Abstract] [Full Text] [Related]

  • 38. [Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
    Hirota T, Fujimoto T, Katano N, Tsurasawa M, Eguchi H, Nakadate N, Kamitamari A, Kawakami K, Nishikawa K, Asami K, Shirahata A, Koizumi S, Mugishima H, Gushiken T, Hyakuna N, Imaizumi M, Komatu K, Takitani K, Miyake M, Yanase T.
    Rinsho Ketsueki; 1997 Nov 23; 38(11):1177-82. PubMed ID: 9423334
    [Abstract] [Full Text] [Related]

  • 39. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H, Sutton L, Duarte M, Daniel MT, Leblond V, Castaigne S, Degos L.
    Leukemia; 1992 Dec 23; 6(12):1237-42. PubMed ID: 1453767
    [Abstract] [Full Text] [Related]

  • 40. All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
    Masetti R, Vendemini F, Zama D, Biagi C, Gasperini P, Pession A.
    Expert Rev Anticancer Ther; 2012 Sep 23; 12(9):1191-204. PubMed ID: 23098119
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.